SlideShare une entreprise Scribd logo
1  sur  20
Télécharger pour lire hors ligne
Participants
Shoaib Ahmad 020
Saira Fiaz 021
Muhammad Sohaib 022
Introduction
Toxicokinetics: - is defined as the generation of pharmacokinetics
data to design, conduct & Interpretation of drug safety evaluation
studies.
• Preclinical drug safety evaluation or toxicological studies .
• In these studies a minimum of two animal species are
employed, as per
regulation of FDA (Food and Drug administration).
• 1)Rodents.
• 2)Non-rodents.
General principle to be considered
A. Quantification of exposure .
B. setting of dose levels
1. Low dose levels .
2. Intermediate dose levels .
3. High dose levels .
C. Extent of exposure assessment in toxicity studies .
D. Complicating factors in exposure interpretation .
E. Route of administration.
F. Determination of metabolites .
G. Statistical evaluation of data.
H. Analytical methods .
I. Reporting
Toxicokinetics studies in preclinical stages
Toxicokinetic studies in Preclinical stage:
 Safety assessment:
 Generally safety of a molecule can be performed in in-vivo systems. This step is
not included in the guidelines but it is very useful for the researchers to assess the
systemic exposure .
 Single dose and rising dose studies :
 These studies are usually performed in rodents.
 Plasma samples may be taken in such studies and stored for later analysis.
 Results from single-dose kinetic studies may help in the choice of formulation
and in the prediction of rate and duration of exposure during a dosing interval.
 This may assist in the selection of appropriate dose levels for use in later studies.
 Rising-dose studies are performed in non-rodent models. Here, toxicokinetic
evaluation takes place at various time-points for each new dose level.
Repeated-dose toxicity studies :
This study is carried out for four weeks in both rodents as well as
non-rodents.
Help to support dose-selection for subsequent studies .
Performing further repeated dose studies in both rodent and non
rodents up to 6-12 months enable estimation of drug and its
metabolite(s) kinetic parameter assessment as well as long term
clinical exposure assessment.
Genotoxicity studies :
Two in vitro studies and one in vivo study is essential to support
development of drug.
In vivo investigations usually use a rodent micronucleus (bone
marrow or peripheral erythrocytes) test or chromosome aberration
(bone marrow cells) test.
Reproduction toxicity studies :
 Reproduction toxicity measurements are taken in studies of fertility (rat),
embryo-foetal development (rat and rabbit) and pre-or post-natal
development (rat).
Studies of fertility :
 Assessment of fertility toxicity has very important, because most of the
drugs used in fertility conditions so has to
strengthen at that time. Usually this can be done in rats.
In pregnant and lactating animals:
 There is a regulatory expectation for Toxicokinetics data in pregnant
animals, although no specific guidance is given.
 Toxicokinetics may involve exposure assessment of dams, embryos, fetuses
or newborn at specified days.
 Secretion in milk may be assessed to define its role in the exposure of
newborns.
Carcinogenicity studies:
Sometimes drugs are used for longtime for curing
purposes, this may lead to the toxicity or carcinogenicity.
So lifetime studies in the rodent are needed to support the
long-term clinical use of pharmaceuticals and non-
rodents can also be used.
Monitoring should occur occasionally i.e. more than six
months is not necessary.
However, pharmaceutical companies use various strategies
for such monitoring times (e.g. Weeks 1, 13, 26 and 52)
Importance and applications
Generation of kinetic data for systemic exposure and
toxicity assessment of the drug.
Simply it means if the safety/risk ratio is balanced or safety
is more then it will be used as good therapeutic agent.
Important in drug development stages especially in
preclinical stage.
TK evaluation is useful for the setting safe dose level in
clinical phases.
TK evaluation is useful in selection of dose, dosing form,
alternative dosing route, evaluation of toxicological
mechanism, and also used for the setting safe dose level in
clinical phases.
Continue.
Toxicokinetic data is important to know the toxic response
to that of drug exposure obtained in drug development
stages.
It is used to set safe dose for clinical use of new drugs.
Useful in the understanding of differences in responses or
sensitivity between individual animals, genders, species or
life stages, and supporting the extrapolation of findings in
experimental animals to humans.
Even though toxicokinetic evaluation is only a small part of
the process of understanding the fate of a drug, it has a
vital part in drug development a role that proceeds to
advance.
Different techniques to be used as
an alternative to an animal testing.
• Full thickness skin model (in-vitro method).
• In silico methods.
• Cell line techniques.
• Patch clamp method
In vitro method
 Instead of using animals, cell and tissue cultures can be
used to test product ingredients.
 Cell culture experiments can show, for example, the lowest
concentration at which aningredient causes damage to
cells.
 The results enable conclusions to be drawn about the
ingredient’s compatibility with tissue.
 Cell cultures are now also used routinely to test substances
for mutagenic properties.
 Tissue cultures are additionally used to test substances for
compatibility with mucous membranes.
In- Silico method
 Substances with similar chemical structures often have similar properties.
 In these cases, therefore, a knowledge of the properties of a few representative
substances is sufficient to be able to deduce the properties of a series of similar
substances.
 By analogy, certain properties of these representative substances can also be
assumed to be properties of the other substances in the series.
 The required calculations are performed using specially developed computer
programs.
 It is anticipated that combinations of such calculations will make it possible to
narrow down the number of substances to be tested.
 Only these selected substances will then have to be tested according to the
legally prescribed test methods.
Cell line techniques
The term cell line refers to the propagation of culture after
the first subculture.
Once the primary culture is sub cultured, it becomes a cell
line.
A cell line derived by selection or cloning is referred to as
cell strain.
Cell strain do not have infinite life, as they die after some
divisions.
Types of cells used in cell line:
a)Precursor/ stem cells/ master cells.
b)Undifferentiated but committed precursor cells.
c)Mature differentiated cells.
APPLICATIONS OF CELL LINE
 Screening of anti cancer drugs
 Cell based bioassays.
 To determine the cytotoxicity.
 In vitro screening of several drugs.
 Production of anti viral vaccines
 Cancer research, which require the study of uncontrolled cell division in
culture.
 Cell fusion technique.
 Genetic manipulation.
 Gene therapy.
 Recombinant DNA therapy.
 Biotechnology.
 Molecular biology……etc.
PATCH CLAMP TECHNIQUE:
The Technique was developed by Erwin neher & bert
Sakman.
Patch clamp technique is a technique in
electrophysiology that allows the study of individual ion
channels in cells.
The technique is used to study excitable cells such as
neurons, muscle fibers and the beta cells of the
pancreas.
PROCEDURE:
 The patch clamp technique can be applied to cultured kidney cells
freshly isolated kidney cells or to cells of isolated perfused kidney
tubules.
 Segments of late superficial proximal tubules of rabbit kidney are
dissected and perfused from one end with a perfusion system.
 The non-cannulated end of the tubule is freely accessible to a patch
pipette the patch pipette can be moved through the open end into the
tubule lumen and is brought in contact with the brush border
membrane.
 After slight suction of the patch electrode, giga seals for
instantaneously and single potassium or sodium channels can be
recorded in the cellattached or inside-outcell –excised modal.
 In order to obtain exposed lateral cell membranes suitable
to the application of the patch clamp method , pieces of
the tubule are to off by means of a glass pipette.
 As to facilitate the tearing off , the tubules are incubated
for about 5min in 0.5g/L collagen a seat room temperature.
 After tearing off part of the cannulated tubule, clean lateral
cell membranes are exposed at the non-cannulated end.
 The patch pipette can be moved to the lateral cell
membrane and gigaseal scan be obtained.
 It was possible, to investigate potassium channels and
nonselective cations channels in these membranes.
EVALUATION:
 In isolated perfused renal tubules , concentration
response curves of drugs which inhibition channel
scan be obtained with the patch clamp technique.
 In isolated cells of the proximal tubule, the whole cell
mode of the patch clamp technique enables the
investigation of the sodium- alanine cotransport
system.
Toxicokinetics

Contenu connexe

Tendances

test item characterization.pptx
test item characterization.pptxtest item characterization.pptx
test item characterization.pptxShobhiniChandel
 
Safety Pharmacology
Safety PharmacologySafety Pharmacology
Safety PharmacologyPavana K A
 
Reproductive toxicology studies
Reproductive toxicology studiesReproductive toxicology studies
Reproductive toxicology studieskusuma khushi
 
Assignment on Reproductive toxicology studies
Assignment on Reproductive toxicology studiesAssignment on Reproductive toxicology studies
Assignment on Reproductive toxicology studiesDeepak Kumar
 
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal IrritationToxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal IrritationShubhu20
 
Assignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical TrialsAssignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical TrialsDeepak Kumar
 
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptxROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptxE Poovarasan
 
PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology Naveen K L
 
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxTEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxashharnomani
 
Safety pharmacology (siri)
Safety pharmacology (siri)Safety pharmacology (siri)
Safety pharmacology (siri)Ramavath Aruna
 
SAFETY PHARMACOLOGY STUDIES final .pptx
SAFETY PHARMACOLOGY STUDIES final .pptxSAFETY PHARMACOLOGY STUDIES final .pptx
SAFETY PHARMACOLOGY STUDIES final .pptxRushikeshTidake
 
Screening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationScreening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationpradnya Jagtap
 
Clinical trial study team
Clinical trial study teamClinical trial study team
Clinical trial study teamManjuJhakhar
 
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyToxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyJanhaviBurade
 
Oral toxicity
Oral toxicityOral toxicity
Oral toxicityDiana Lou
 
DRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGN
DRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGNDRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGN
DRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGNAADYARAJPANDEY1
 

Tendances (20)

test item characterization.pptx
test item characterization.pptxtest item characterization.pptx
test item characterization.pptx
 
Safety Pharmacology
Safety PharmacologySafety Pharmacology
Safety Pharmacology
 
Kk Test item characterization
Kk Test item characterizationKk Test item characterization
Kk Test item characterization
 
Reproductive toxicology studies
Reproductive toxicology studiesReproductive toxicology studies
Reproductive toxicology studies
 
Assignment on Reproductive toxicology studies
Assignment on Reproductive toxicology studiesAssignment on Reproductive toxicology studies
Assignment on Reproductive toxicology studies
 
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal IrritationToxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
 
Assignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical TrialsAssignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical Trials
 
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptxROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
 
PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology
 
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxTEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
 
hERG Assay
hERG Assay hERG Assay
hERG Assay
 
Safety pharmacology (siri)
Safety pharmacology (siri)Safety pharmacology (siri)
Safety pharmacology (siri)
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
SAFETY PHARMACOLOGY STUDIES final .pptx
SAFETY PHARMACOLOGY STUDIES final .pptxSAFETY PHARMACOLOGY STUDIES final .pptx
SAFETY PHARMACOLOGY STUDIES final .pptx
 
Screening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationScreening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentization
 
Clinical trial study team
Clinical trial study teamClinical trial study team
Clinical trial study team
 
Invivo Carcinogenecity Studies
Invivo Carcinogenecity StudiesInvivo Carcinogenecity Studies
Invivo Carcinogenecity Studies
 
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyToxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
 
Oral toxicity
Oral toxicityOral toxicity
Oral toxicity
 
DRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGN
DRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGNDRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGN
DRUG DISCOVERY :TRADITIONAL VS RATIONAL DRUG DESIGN
 

Similaire à Toxicokinetics

Assignment on Toxicokinetics
Assignment on ToxicokineticsAssignment on Toxicokinetics
Assignment on ToxicokineticsDeepak Kumar
 
Assignment on Alternatives to Animal Screening Method
Assignment on Alternatives to Animal Screening MethodAssignment on Alternatives to Animal Screening Method
Assignment on Alternatives to Animal Screening MethodDeepak Kumar
 
Alternatives to animal screening methods p'screening. mohammadhusain
Alternatives to animal screening methods p'screening. mohammadhusainAlternatives to animal screening methods p'screening. mohammadhusain
Alternatives to animal screening methods p'screening. mohammadhusainVasaya Mohammadhusain
 
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxAnmolkanda06
 
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kineticspharmacistnitish
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxashharnomani
 
Alternative to animal studies
Alternative to animal studiesAlternative to animal studies
Alternative to animal studiespaulvitrion91
 
Experimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.pptExperimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.pptKarabiAdak
 
Extrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptxExtrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptxARSHIKHANAM4
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discoveryaiswarya thomas
 
1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.Audumbar Mali
 
safety data generation.pptx
safety data generation.pptxsafety data generation.pptx
safety data generation.pptxGayatriBahatkar1
 
toxicokinetics-1.pptx
toxicokinetics-1.pptxtoxicokinetics-1.pptx
toxicokinetics-1.pptxUnnatikhare1
 
Toxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoveryToxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoverySuhas Reddy C
 
Cell culture and its types
Cell culture and its typesCell culture and its types
Cell culture and its typesPankaj Maurya
 
Preclinical drug discovery and development
Preclinical drug discovery and developmentPreclinical drug discovery and development
Preclinical drug discovery and developmentsamthamby79
 
Pre clinical studies
Pre clinical studiesPre clinical studies
Pre clinical studiesKirsha K S
 
Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical IndustryCurrent Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical IndustryProf. Dr. Basavaraj Nanjwade
 

Similaire à Toxicokinetics (20)

Assignment on Toxicokinetics
Assignment on ToxicokineticsAssignment on Toxicokinetics
Assignment on Toxicokinetics
 
Assignment on Alternatives to Animal Screening Method
Assignment on Alternatives to Animal Screening MethodAssignment on Alternatives to Animal Screening Method
Assignment on Alternatives to Animal Screening Method
 
Alternatives to animal screening methods p'screening. mohammadhusain
Alternatives to animal screening methods p'screening. mohammadhusainAlternatives to animal screening methods p'screening. mohammadhusain
Alternatives to animal screening methods p'screening. mohammadhusain
 
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
 
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kinetics
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptx
 
Alternative to animal studies
Alternative to animal studiesAlternative to animal studies
Alternative to animal studies
 
Experimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.pptExperimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.ppt
 
Extrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptxExtrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptx
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discovery
 
1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.
 
safety data generation.pptx
safety data generation.pptxsafety data generation.pptx
safety data generation.pptx
 
toxicokinetics-1.pptx
toxicokinetics-1.pptxtoxicokinetics-1.pptx
toxicokinetics-1.pptx
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Toxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoveryToxicological Approach to Drug Discovery
Toxicological Approach to Drug Discovery
 
Cell culture and its types
Cell culture and its typesCell culture and its types
Cell culture and its types
 
Preclinical drug discovery and development
Preclinical drug discovery and developmentPreclinical drug discovery and development
Preclinical drug discovery and development
 
Pre clinical studies
Pre clinical studiesPre clinical studies
Pre clinical studies
 
Alternative animal experimentation technique
Alternative animal experimentation techniqueAlternative animal experimentation technique
Alternative animal experimentation technique
 
Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical IndustryCurrent Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
 

Dernier

On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701bronxfugly43
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxAmanpreet Kaur
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Jisc
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17Celine George
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfSherif Taha
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfNirmal Dwivedi
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentationcamerronhm
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptxMaritesTamaniVerdade
 

Dernier (20)

On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 

Toxicokinetics

  • 1. Participants Shoaib Ahmad 020 Saira Fiaz 021 Muhammad Sohaib 022
  • 2. Introduction Toxicokinetics: - is defined as the generation of pharmacokinetics data to design, conduct & Interpretation of drug safety evaluation studies. • Preclinical drug safety evaluation or toxicological studies . • In these studies a minimum of two animal species are employed, as per regulation of FDA (Food and Drug administration). • 1)Rodents. • 2)Non-rodents.
  • 3. General principle to be considered A. Quantification of exposure . B. setting of dose levels 1. Low dose levels . 2. Intermediate dose levels . 3. High dose levels . C. Extent of exposure assessment in toxicity studies . D. Complicating factors in exposure interpretation . E. Route of administration. F. Determination of metabolites . G. Statistical evaluation of data. H. Analytical methods . I. Reporting
  • 4. Toxicokinetics studies in preclinical stages Toxicokinetic studies in Preclinical stage:  Safety assessment:  Generally safety of a molecule can be performed in in-vivo systems. This step is not included in the guidelines but it is very useful for the researchers to assess the systemic exposure .  Single dose and rising dose studies :  These studies are usually performed in rodents.  Plasma samples may be taken in such studies and stored for later analysis.  Results from single-dose kinetic studies may help in the choice of formulation and in the prediction of rate and duration of exposure during a dosing interval.  This may assist in the selection of appropriate dose levels for use in later studies.  Rising-dose studies are performed in non-rodent models. Here, toxicokinetic evaluation takes place at various time-points for each new dose level.
  • 5. Repeated-dose toxicity studies : This study is carried out for four weeks in both rodents as well as non-rodents. Help to support dose-selection for subsequent studies . Performing further repeated dose studies in both rodent and non rodents up to 6-12 months enable estimation of drug and its metabolite(s) kinetic parameter assessment as well as long term clinical exposure assessment. Genotoxicity studies : Two in vitro studies and one in vivo study is essential to support development of drug. In vivo investigations usually use a rodent micronucleus (bone marrow or peripheral erythrocytes) test or chromosome aberration (bone marrow cells) test.
  • 6. Reproduction toxicity studies :  Reproduction toxicity measurements are taken in studies of fertility (rat), embryo-foetal development (rat and rabbit) and pre-or post-natal development (rat). Studies of fertility :  Assessment of fertility toxicity has very important, because most of the drugs used in fertility conditions so has to strengthen at that time. Usually this can be done in rats. In pregnant and lactating animals:  There is a regulatory expectation for Toxicokinetics data in pregnant animals, although no specific guidance is given.  Toxicokinetics may involve exposure assessment of dams, embryos, fetuses or newborn at specified days.  Secretion in milk may be assessed to define its role in the exposure of newborns.
  • 7. Carcinogenicity studies: Sometimes drugs are used for longtime for curing purposes, this may lead to the toxicity or carcinogenicity. So lifetime studies in the rodent are needed to support the long-term clinical use of pharmaceuticals and non- rodents can also be used. Monitoring should occur occasionally i.e. more than six months is not necessary. However, pharmaceutical companies use various strategies for such monitoring times (e.g. Weeks 1, 13, 26 and 52)
  • 8.
  • 9. Importance and applications Generation of kinetic data for systemic exposure and toxicity assessment of the drug. Simply it means if the safety/risk ratio is balanced or safety is more then it will be used as good therapeutic agent. Important in drug development stages especially in preclinical stage. TK evaluation is useful for the setting safe dose level in clinical phases. TK evaluation is useful in selection of dose, dosing form, alternative dosing route, evaluation of toxicological mechanism, and also used for the setting safe dose level in clinical phases.
  • 10. Continue. Toxicokinetic data is important to know the toxic response to that of drug exposure obtained in drug development stages. It is used to set safe dose for clinical use of new drugs. Useful in the understanding of differences in responses or sensitivity between individual animals, genders, species or life stages, and supporting the extrapolation of findings in experimental animals to humans. Even though toxicokinetic evaluation is only a small part of the process of understanding the fate of a drug, it has a vital part in drug development a role that proceeds to advance.
  • 11. Different techniques to be used as an alternative to an animal testing. • Full thickness skin model (in-vitro method). • In silico methods. • Cell line techniques. • Patch clamp method
  • 12. In vitro method  Instead of using animals, cell and tissue cultures can be used to test product ingredients.  Cell culture experiments can show, for example, the lowest concentration at which aningredient causes damage to cells.  The results enable conclusions to be drawn about the ingredient’s compatibility with tissue.  Cell cultures are now also used routinely to test substances for mutagenic properties.  Tissue cultures are additionally used to test substances for compatibility with mucous membranes.
  • 13. In- Silico method  Substances with similar chemical structures often have similar properties.  In these cases, therefore, a knowledge of the properties of a few representative substances is sufficient to be able to deduce the properties of a series of similar substances.  By analogy, certain properties of these representative substances can also be assumed to be properties of the other substances in the series.  The required calculations are performed using specially developed computer programs.  It is anticipated that combinations of such calculations will make it possible to narrow down the number of substances to be tested.  Only these selected substances will then have to be tested according to the legally prescribed test methods.
  • 14. Cell line techniques The term cell line refers to the propagation of culture after the first subculture. Once the primary culture is sub cultured, it becomes a cell line. A cell line derived by selection or cloning is referred to as cell strain. Cell strain do not have infinite life, as they die after some divisions. Types of cells used in cell line: a)Precursor/ stem cells/ master cells. b)Undifferentiated but committed precursor cells. c)Mature differentiated cells.
  • 15. APPLICATIONS OF CELL LINE  Screening of anti cancer drugs  Cell based bioassays.  To determine the cytotoxicity.  In vitro screening of several drugs.  Production of anti viral vaccines  Cancer research, which require the study of uncontrolled cell division in culture.  Cell fusion technique.  Genetic manipulation.  Gene therapy.  Recombinant DNA therapy.  Biotechnology.  Molecular biology……etc.
  • 16. PATCH CLAMP TECHNIQUE: The Technique was developed by Erwin neher & bert Sakman. Patch clamp technique is a technique in electrophysiology that allows the study of individual ion channels in cells. The technique is used to study excitable cells such as neurons, muscle fibers and the beta cells of the pancreas.
  • 17. PROCEDURE:  The patch clamp technique can be applied to cultured kidney cells freshly isolated kidney cells or to cells of isolated perfused kidney tubules.  Segments of late superficial proximal tubules of rabbit kidney are dissected and perfused from one end with a perfusion system.  The non-cannulated end of the tubule is freely accessible to a patch pipette the patch pipette can be moved through the open end into the tubule lumen and is brought in contact with the brush border membrane.  After slight suction of the patch electrode, giga seals for instantaneously and single potassium or sodium channels can be recorded in the cellattached or inside-outcell –excised modal.
  • 18.  In order to obtain exposed lateral cell membranes suitable to the application of the patch clamp method , pieces of the tubule are to off by means of a glass pipette.  As to facilitate the tearing off , the tubules are incubated for about 5min in 0.5g/L collagen a seat room temperature.  After tearing off part of the cannulated tubule, clean lateral cell membranes are exposed at the non-cannulated end.  The patch pipette can be moved to the lateral cell membrane and gigaseal scan be obtained.  It was possible, to investigate potassium channels and nonselective cations channels in these membranes.
  • 19. EVALUATION:  In isolated perfused renal tubules , concentration response curves of drugs which inhibition channel scan be obtained with the patch clamp technique.  In isolated cells of the proximal tubule, the whole cell mode of the patch clamp technique enables the investigation of the sodium- alanine cotransport system.